[The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002250:Carbon Radioisotopes; D003517:Cyclopentanes / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood; D004794:Enzyme Repression; D006003:Glycogen / Q000378:metabolism; D006006:Glycogen Synthase / Q000037:antagonists & inhibitors*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D011758:Pyrroles / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D002250:Carbon Radioisotopes; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D006003:Glycogen; D006006:Glycogen Synthase
Effets "in vitro" du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normales